Collaborative Neuroscience Research, LLC
Long Beach 2600 Redondo Avenue, Suite 500, Long Beach, CA 90806 MAP
Orange County 12772 Valley View St., Suite 3, Garden Grove, CA 92845 MAP
South Bay 19401 S. Vermont Avenue, Suite F-100, Torrance, CA 90502 MAP
Founded in 2000, Collaborative Neuroscience Research (CNS Research) has grown to become the largest clinical research provider in Southern California. CNS Research operates three outpatient clinics located in Long Beach, Garden Grove, and Torrance. Additionally, its Long Beach location features a 60-bed Clinical Pharmacology Unit (CPU) specially designed for early phase research as well as a purpose-built 16-bed Asian Studies unit to support global development for Japan, Korea, China.
CNS Research offers an outstanding team of experts who oversee the setup and conduct of each clinical study. Dr. David Walling, CEO and Principal Investigator, has participated as a lead or co-investigator in hundreds of Phase I-IV clinical studies, with many focusing on schizophrenia, an indication for which he has KOL status. He has extensive experience advising leading pharmaceutical sponsors in the design and analysis of clinical trials in all phases. Dr. Larry Ereshefsky, CSO, Early Phase Development, is an internationally recognized thought leader in clinical translational central nervous system research. Under their leadership, CNS Research is well-positioned to provide the scientific guidance and operational expertise needed to ensure the success of its clinical research.
CNS Research has a long history of consistent subject recruitment and retention. With locations in ethnically diverse metropolitan areas, a subject database with 90,000 individuals, and an experienced dedicated recruitment staff comprised of 20+ outreach and recruitment specialists, CNS Research is well-positioned to meet enrollment goals within timelines.
Download the CNS Research fact sheet.
Clinical Pharmacology Unit (CPU)
CNS Research’s Early Phase research facility is centrally located in the Los Angeles metropolitan market less than 1/4 mile from the Long Beach Airport.
- 50,000 sq ft state-of-the-art facility specially designed for early phase research
- Phase I unit with 60+ beds for healthy subjects and stable patients
- Provides an array of services that are critical to the successful completion of complex and adaptive design studies
- Secure medication dispensary and CLIA Waived lab
- Dedicated driving simulator rooms with six state-of-the-art CRCDS MiniSim driving simulators
Download a presentation about the CPU.
David Walling, PhD, CEO, Principal Investigator. Licensed Clinical Psychologist.
Larry Ereshefsky, PharmD, CSO. Internationally recognized thought leader in clinical translational central nervous system research.
Brett A. English, Pharm.D., Ph.D., Vice President of Scientific Affairs. Expert in program planning and electrophysiology, imaging, and pharmacodynamic biomarker applications.
Armen Goenjian, MD, CMO, Principal Investigator. Board Certified Psychiatrist.
Omid Omidvar, MD, Principal Investigator. Board Certified Neurologist.
Steven Reynolds, DO, Principal Investigator. Board Certified Family Practitioner.
Nirav Patel, MD, Principal Investigator. Board Certified Neurologist.
Lara Shirikjian, DO, Principal Investigator. Board Certified Psychiatrist.
Haig Goenjian, MD, Principal Investigator. Board Certified Psychiatrist.
Seanglong Te, MD, Principal Investigator. Board Certified Family Practitioner.